Apellis Pharmaceuticals Inc. logo

Apellis Pharmaceuticals Inc. (APLS)

Delisted
15 May 2026
NASDAQ (NGS) NASDAQ (NGS)
$
41. 03
0
0%
After Hours
$
41. 05
+0.02 +0.0487%
5.25B Market Cap
- P/E Ratio
- Div Yield
28.64M Volume
-4.51 Eps
$ 41.03
Previous Close
Day Range
41.03 41.05
Year Range
16.61 41.14
Want to track APLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Apellis Pharmaceuticals Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
RW
Riley Wancket HANTZ FINANCIAL SERVICES Inc.
2,836 $114 $114 - -
DB
David Barlow Glazer Capital LLC
1.29M $52.07M $52.07M - -
MB
Mitchel Bialek Css LLC/IL
42,818 $1,722.57 $1,722.57 - -
KM
Kristin Mariani Janus Henderson Group PLC
230,320 $7.19M $9.27M $2.07M 28.85%
RAS
Robert A. Saperstein Guggenheim Capital LLC
56,801 $2,224.04 $2,285.11 $61.07 2.75%
KJD
Kathryn J. Daniels Canada Pension Plan Investment Board
19,600 $445,552 $788,508 $342,956 76.97%
CW
CaSaundra Wu Westchester Capital Management LLC
227,489 $9.15M $9.15M - -
LA
Lina Arias Stelac Advisory Services LLC
5,520 $124.92 $222.07 $97.15 77.77%
David Jarvis
David Jarvis Corton Capital Inc.
18,427 $318.97 $417 $98.03 30.73%
VT
Vincent Tortorella Point72 (DIFC) Ltd
14,591 $330,195 $330,195 - -
Charles Hillier
Charles Hillier Cibra Capital Ltd.
50,000 $2.01M $2.01M - -
Evelyn Partners Investment Management LLP
Evelyn Partners Investment Management LLP Evelyn Partners Investment Management LLP
150 $357.52 $2,594 $2,236.48 625.55%